-
Risk of Mortality Following Catheter Ablation of Atrial FibrillationEP Cheng, CF Liu, JW Cheung et al. -
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV TrialF Cosentino , CP Cannon , DZI Cherney et al.
-
When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney diseaseE O'Meara, S Verma.
-
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic AnalysisAL Beale, S Nanayakkara, L Segan et al.
-
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection FractionBeale AL, Meyer P, Kaye DM et al.
-
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF RegistriesKi Hong Choi Jin‐Oh Choi et al.
-
Mechanical circulatory support devices in advanced heart failure: 2020 and beyondJL Vieira, HO Ventura, MR Mehra et al.
-
Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) TrialB Pieske, MJ Patel, VICTORIA Study Group et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
